Hussain Al-Mannai
“Dubai, UAE – January 4, 2024: The 29th edition of the Dubai International Pharmaceutical and Technology Conference and Exhibition (Dufat 2024) is set to kick off next week, spanning three days from January 9 to 11 at the Dubai World Trade Centre. This event is the largest gathering of pharmaceutical companies in the Middle East and Africa, expected to witness its biggest turnout since its inception, attracting over 32,000 visitors and participants from around the world.
Over the past 28 years, Dufat has established itself as a unique global platform, bringing together experts in the pharmaceutical sector. The exhibition provides exceptional facilities for drug suppliers and industry leaders to showcase the latest pharmaceutical products, technologies, and solutions, facilitating the exchange of information, ideas, insights, and innovations in the pharmaceutical sector and its technologies. It also serves as a platform to review the latest developments in drugs and patient care.
The pharmaceutical market in the UAE is expected to exceed $4.7 billion by 2025, indicating a significant growth of 27% over the past five years. The UAE offers more than 2,500 locally manufactured medicines, reflecting the country’s strong and distinctive manufacturing capabilities in the pharmaceutical sector. Global estimates suggest that the pharmaceutical market in the Middle East and North Africa exceeds $50 billion, reinforcing the region’s position in the global pharmaceutical and drug industry. Dufat goes beyond being a pharmaceutical event, embodying an inspirational journey where knowledge meets innovation, shaping a brighter future for healthcare.
Dufat 2024 will host participants from 95 countries worldwide, including 150 speakers delivering 120 lectures and 16 workshops. The event will also feature university students presenting 350 scientific posters on the latest medical research and innovations in the sector. The exhibition, spanning halls 1 to 8 at the Dubai World Trade Centre, offers 63 Continuing Medical Education (CME) points accredited by the Dubai Health Authority and 22 points in Continuing Professional Development (CPD) from the Hospital Pharmacists Society in Australia.
Simultaneously, the event will host “The Pharma Business Hub,” facilitating direct communication with high-level decision-makers from leading exhibitors at Dufat.
Dr. Abdul Salam Al Madani, CEO of Dufat, stated, ‘Dufat 2024 continues its strong commitment to enhancing the highest standards in the pharmaceutical industry by providing high-quality products and innovative technology. This year marks a significant achievement, reaching the largest size since its inception, reinforcing the value of this event and confirming its global status.’
As a beacon of innovation, Dufat 2024 presents an enormous amount of medical information and research, contributing to propelling the pharmaceutical industry towards new horizons. It serves as a key platform for development and a fundamental trading platform, fostering communication in one of the fastest-evolving business sectors.
Dufat 2024 brings together over three days a select group of regional and international experts, pharmaceutical professionals, and leaders to discuss the future of the profession and continuous improvement strategies. The main topics of the conference include drug safety, advancements in drug therapy and its challenges, patient perspectives, the role of pharmacists, and methods of developing pharmacy practice.
Dr. Ali Al Sayed Hussain, President of Dufat, commented, ‘Dufat aspires to be the main platform for pharmacists, industry workers, marketing experts, academics, researchers, scientists, students, and relevant healthcare professionals to participate and engage effectively. This enhances the exchange of knowledge and experiences in the ever-evolving world of pharmacy, contributing to the ongoing efforts to meet challenges and fulfill patient expectations even in the toughest conditions. Therefore, we must continue to align our working methods, enhance innovation to remain at the forefront of excellence, and keep pace with all developments.’
Dufat 2024 allows pharmaceutical companies the opportunity to launch new products, keep up with technological developments, gain scientific knowledge and experiences, engage with industry peers, and explore solutions to address sector challenges. Specialized sessions will address the issue of the proper use of non-prescription products, reflecting the significant awareness and growth in this field in recent years.
The Dubai International Pharmaceutical and Technology Conference and Exhibition – Dufat 2024 is organized by Index Conferences and Exhibitions, a member of Index Holding, with the support of the Dubai Health Authority, the American Society of Health-System Pharmacists, the International Pharmaceutical Federation, the European Federation for Clinical Pharmacy, the European Society of Oncology Pharmacy, and the Society of Hospital Pharmacists of Australia.
